Friday
SESSION 87: NEW DEVELOPMENTS IN MEDICAL AND DRUG TREATMENTS: BEST ANTIPLATELET REGIMENS; UPDATE ON RARE VASCULAR DISEASES
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
Moderators:Caron B. Rockman, MD / James H. Black, III, MD  
SESSION 87 SCHEDULE
ANTIPLATELET REGIMENS
2:30 PM - 2:35 PM

Power Point Presentation with Synched Audio
Optimal Antiplatelet Management With CEAs, Lower Extremity Bypasses And Open AAA Repairs
  Presenter(s):David H. Stone, MD  
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
  View Slides in PDF      
2:36 PM - 2:41 PM Optimal Anticoagulation And Antiplatelet Treatment For High Risk Lower Extremity Bypasses Vein And PTFE
  Presenter(s):Peter Henke, MD  
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
  View Slides in PDF      
2:42 PM - 2:47 PM Most Effective Antiplatelet After Lower Extremity Interventional Treatments For CLTI POBA, DCBs, Stents, Etc.
  Presenter(s):Maciej L. Dryjski , MD, PhD  
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
  View Slides in PDF      
2:48 PM - 2:53 PM Why Clopidogrel Is Effective In <50% Of Patients At Standard Doses: How To Identify And Fix This Problem
  Presenter(s):Karthik Kasirajan, MD  
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
  View Slides in PDF      
NEW DEVELOPMENTS IN LIPID MANAGEMENT STATINS
2:54 PM - 2:59 PM Safety And Benefit Of Statins And Medical Treatment In Vascular Patients: Shockingly These Treatments Are Underutilized Especially In Women: Why Is This So
  Presenter(s):Christian A. Behrendt, MD  
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
  View Slides in PDF      
3:00 PM - 3:05 PM Value Of Statins In AAA Patients After Repair: Long-Term Impact On Mortality
  Presenter(s):Adam Beck, MD  
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
  View Slides in PDF      
3:06 PM - 3:11 PM The Importance Of Lipoprotein Little a [Lp(a)] Levels In Determining Atherosclerotic Risk: When Should It Be Measured And If High, How Treated: Do PCSK-9 Inhibitors Help
  Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC   
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
  View Slides in PDF      
3:12 PM - 3:18 PM Panel Discussion
3:18 PM - 3:23 PM Elevated Neutrophil To Lymphocyte Ratio Predicts Poor Outcomes And Mortality After Elective EVAR And CEA: What Is The Mechanism
  Presenter(s):Jae S. Cho, MD  
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
  View Slides in PDF      
3:24 PM - 3:29 PM The Justification For Carotid Screening Is To Promote Medical Treatment To Decrease Stroke And MI Risks, Not To Push Patients To Have Unnecessary Invasive Procedures
  Presenter(s):Kosmas I. Paraskevas, MD  
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
  View Slides in PDF      
3:30 PM - 3:35 PM Lowering LDL-C And Controlling Elevated Blood Pressure Can Lower Cardiovascular Risk 80%: Doing These Things Should Be A Lifetime Goal
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
  View Slides in PDF      
3:36 PM - 3:41 PM How To Make Operations For Complications Of Vascular Ehlers Danlos Syndrome Go Well
  Presenter(s):James H. Black, III, MD  
Location: LECTURE HALL 2 - FLORIDIAN BALLROOM
  View Slides in PDF      
3:42 PM - 3:48 PM Panel Discussion
END OF SESSION 87
previous next